SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-087239
Filing Date
2016-03-10
Accepted
2016-03-10 16:32:58
Documents
3
Period of Report
2016-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v433778_8k.htm 8-K 18013
2 EXHIBIT 99.1 v433778_ex99-1.htm EX-99.1 83743
3 GRAPHIC image_001.jpg GRAPHIC 5687
  Complete submission text file 0001144204-16-087239.txt   110930
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 161498193
SIC: 2834 Pharmaceutical Preparations